MENU

S&P/ASX 200 open Monday: 8 shares to watch

The S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) is expected to open lower on Monday, with shares of RCG Corporation Ltd (ASX: RCG) and Catapult Group International Ltd (ASX: CAT) in focus.

Here’s a quick recap of global markets:

  • FTSE 100 (UK): down 0.5%
  • DAX (Germany): down 0.1%
  • CAC 40 (France): down 0.1%
  • Dow Jones (USA): down 0.2%
  • NASDAQ (USA): flat

In London, the blue chip index (FTSE 100) ended firmly lower on Friday as banks weighed on the market. FTSE-listed shares of BHP Billiton Limited (ASX: BHP) and Rio Tinto Limited (ASX: RIO) ended 1.9% and 1.1% higher, respectively.

In the U.S, markets ended lower following a disappointing first quarter GDP reading.

Closer to home, the ASX 200 is expected to open slightly lower today, following global markets.

Shares in focus will be the big banks, including National Australia Bank Ltd. (ASX: NAB) and Macquarie Group Ltd (ASX: MQG), ahead of their reports later this week.

In company-specific news, RCG Corporation, the owner of The Athlete’s Foot and more, today reported a market downgrade saying sales have fallen short of management’s expectations. Concerningly, the RCG share price has fallen 24% over the past month.

Shares of technology business Catapult Group International have entered a trading halt, pending a capital raising.

Cimic Group Ltd (ASX: CIM) announced that its subsidiary Leighton Asia has been awarded a $436 million contract in Hong Kong.

Quintis Ltd (ASX: QIN), formally TFS Corporation, reported, “good progress” at Santalis, its pharmaceutical subsidiary.

Finally, analysts at Credit Suisse raised their ResMed Inc. (CHESS) (ASX: RMD) price target 2.6% to $9.70 while UBS analysts cut their AWE Limited (ASX: AWE) price target 4.8% to $0.60, according to Dow Jones Newswires.

Are you thinking of buying ResMed shares? You should try these 3 blue chip dividend share ideas first. They have been hand-picked by our expert analyst.

Just, click here, enter your email address and we'll send you our expert analyst's research report -- completely free.

No payment or credit card details required.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned. Owen welcomes and encourages your feedback. You can follow him on Twitter @OwenRask.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of National Australia Bank Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

HOT OFF THE PRESSES: My #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.